Lecture 4: Factors Influencing Toxicity Flashcards
What are Factors Influencing Toxicity?
Route of exposure (ingestion vs dermal)- QUICKER something gets into the bloodstream the faster the exposure
Endpoints we measure (e.g., death vs gene expression)
Duration of study (acute vs. chronic)
Properties of the compound
Single compound vs. Mixtures
Half-life of the compound
Excretion rate
Tolerance
Resistance
Genetics
Additive
when the total amount of toxicity is the sum of the toxicities of the compounds (2 + 2 = 4)
usually due to the fact that the toxins are very similar - they have similar LD50s and/or their targets of toxicity are the same.
synergistic
when the total amount of toxicity is greater than the sum of the toxicities of the compounds (2 + 2 = 8). - toxic response is greater than what you would predict
Example 1: Workers exposed to asbestos increase risk of lung cancer by 20 times, smokers have a 26 times increase in risk. The combination of the two increases the risk to 400 times.
antagonistic
when the total amount of toxicity is less than the sum of the toxicities of the compounds (2 + 2 = 1). - mixture is causing a less of response than these toxicants on their own
– This is the basis of antidotes!
Give an example of an antidote
For example, when a person OD’s on morphine:
Morphine is a μ-opioid receptor agonist (i.e., activates the receptor). Causes analgesia, sedation, euphoria and respiratory depression. If you take to much, you stop breathing.
Naloxone is a μ-opioid receptor antagonist (i.e., deactivates the receptor). When a person has OD’d on opiates, naloxone is administered. It will block the activation of the receptor and thus is antagonistic to morphine.
Functional antagonism
2 toxicants produce opposite effects on a physiological function. (stimulant vs sedative)
Chemical antagonism
chemical reaction between the compounds leads to an inactivation that produces a less toxic effect.
Dispositional antagonism
alters the absorption, biotransformation, distribution or elimination of the toxicants.
– Concentration or excretion at target tissue is affected
Receptor antagonism
2 toxicants bind to the same receptor and interfere with the response.(naloxone and morphine)
Potentiation
is when a non-toxic chemical(doesn’t create a adverse effect) (at the levels normally administered or encountered) makes a different toxicant even more toxic.
Interactions can occur between________
toxicants and abiotic factors
For example, many aquatic organisms react to compounds in different ways in fresh water vs. salt water.
Provide an example of Potentiation
Warfarin is an anticoagulant (prevents blood clotting).
– Used as a rat poison… also used as a therapy to prevent heart attacks (anti-thrombosis).
It gets bound to albumin (a sticky protein) in the blood which keeps its “free” levels of warfarin concentration down.
If a low (non-toxic) dose of another drug/toxicant that is also carried by albumin is administered… the warfarin gets displaced off the albumin and can quickly reach toxic levels in the blood.
Describe how the some toxicants exist in different chemical forms
These ‘forms’ can be either modified by metabolism by the individual or by environment-driven chemical reactions.
Example: elemental mercury (Hg) is not especially toxic, so its presence in the environment is not usually cause for concern.
However, when it is converted to organic form (methylmercury), it is much more toxic (become lipophilic accumulate in animals and leads to higher levels of mercury in top predators)
*FORM OF COMPOUND CAN DICTATE ITS TOXIC EFFECTS
Genotype
the genetic make up of an individual.
Phenotype
observable traits due to interactions between the genotype and the environment (i.e., tolerance to a toxicant).
Difference in genetic seqence________
can lead to difference in tolerance of toxicants
mutation
Exchanging one nucleotide with another
single nucleotide polymorphisms (SNPs)
Sequence differences between individuals can be measured using this
to identify different genotypes in individuals/populations/species, etc.
– Better resolution than “older” approaches
• Mitochondrial DNA,microsatellites,etc.